Relating to the price of prescription drugs.
Summary
Establishes Prescription Drug Affordability Board in Department of Consumer and Business Services to review prices for prescription drug products meeting specified cost criteria. Requires board to establish upper payment limit for drugs that are or are expected to create affordability challenges for health systems and patients in Oregon or health inequities for communities of color. Requires board to establish and assess fees against manufacturers of prescription drug products sold in Oregon for costs of carrying out duties of board. Establishes Prescription Drug Affordability Stakeholder Council to assist board in carrying out its duties.
Bill status
in committee
1 of 4 stages cleared
Introduction
Feb 2021
Committee Review
Floor Vote
Governor
Introduced Feb 23, 2021
Last action Jun 27, 2021
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
1
Committee
2
Jun 27, 2021
Lower · Passed
In committee upon adjournment.
lower
Feb 26, 2021
Committee
Referred to Health Care with subsequent referral to Ways and Means.
lower
Feb 23, 2021
Introduced
First reading. Referred to Speaker's desk.
lower
1 primary · 1 co-sponsor
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 3267
Scope: OR
Hi! I can help you understand HB 3267. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline